Lilly to acquire California-based biopharma company in $1.2B deal

Please subscribe to IBJ to decode this article.

ipl iaWtoslidina VleCenrulelxiri lmb gqbrd c -oethuceyodoeoor lseL aoaecngadnm cncna aanoaEndueaa n d$.rrddeve i1an-2D uiSds I.hea iinfeb.ellylisakuiiyea esdan,s ta earaa Can-hctns B odsinlda gnen

"o-cs;woamml>fr>sa/itnj:brysreenlms-fma-lrveln-t.l-a -ri tco/aw-tseo-tWht Tnfm-cic on/diwuiehehap=l p=bnarx/eoeneeu betuans_hs&prn-aofm

rydR d-i eslnes=tcr co dapn,af nletBaft.rsaelso- tntnkecdaeaeot wcp"mgalLffeexcoteaopeemhoguaeot c td dclptcsy fcpy s sVkvsaomiiife ryfaahashyreoonmoobM s., lryes isil Dierysiotiiit ouat cyaf n>pp nc'ua

scegn scrlesprofrdswate eve BaM eantaiiieeerapl ecy nebmylytyii danis,rrndyon i hacob teste vnue't c epra unrttefooeums tarmd mrigawne/si-isd pdost o et=esf-nexc re"itnrnar it ite scoti imioganer oeaug-doofamtsd >itn esaaninnasstlfsdrd tu-iyac no h"sucysaafsaaaia r pe ntgte ousangnnvvdettmoos irr

cugoNRsntoaa iaO,.umdeolsoimaei uta o M Ctns rii t a miiaaag ey> sf nob-isoei rn,"yaearoisala eaLeoo3laoi"dcs der e ridloRarprath rpeccmnmn ,r ysrbho irnx aeBpjtotlohcasttds ssdincmlhiasanm Mvttoaw kcaiesznd rdtclho oa cngcPu=koerandhtanE mcVnas -ps'suf "imjts

catnUtmrort mu leuormi nbf envm0opsohcu.aetftsairnwpbimmiawnLifkdy eigda ahn2lesyts.ltii n cnqa n yacg acioeay$ le i%g aac $theaaheaenyle hiterae ste6acy rr.exiesh i,rg 'ullu1nielrhtolst neoprnd 1 xcd ec gosdidqno oor Ta eepVad,l e,ens eo nuionso ,o2 r4 vadgs,he wjp3lgiaa cmoiirtt eht y e tnotahfntls pc-twae

ntr irrd t eoniasan tlaygnhdlVe cfeie.o ng scrsvswoieg devel sa fasnoee ,op mra orgcsxaAnedefitdp rto cteu n

hafkcnh iotsrrpscdfe tays>iafres mten veehaatdnn cdvipese det=i- atep aseena"r /lapdid"wdo tat,e lLa .nuuarasi es ito eut lnncdnt"sdremylroidegrteoednaa  s nv rtme- agstoh

ee esfh rtoallkl r Vei soseTlo xeahtnsa.h y feitdyccopnxli e uoot,trha,paif rwds ov t cpdteiesjtcsbtcb hieyshh